Zebrafish Lacking Neurexin Genes Show Behavioural Changes
Griffith University researchers built a complete set of zebrafish models lacking neurexin genes linked to psychiatric disorders.
Updated on Nov. 18, 2026 in Diseases

Researchers at Griffith University's Institute for Biomedicine and Glycomics created a complete collection of zebrafish models lacking members of the neurexin gene family. The fish showed no obvious brain or behavioural changes early in development, but differences in social behaviour, anxiety and aggression emerged in the juvenile stage and persisted as they matured.
Why it matters
The neurexin gene family is associated with various psychiatric disorders, and the models offer a platform to search for treatments that could prevent, delay or reverse the changes observed. The results do not mean that fish develop schizophrenia or autism in the same way humans do.
The study is a laboratory observation of genetically modified zebrafish, comparing behaviour against unmodified fish across development stages. The team has not yet established the timing or triggers of the circuit divergence behind the changes.
The players
Griffith University
An Australian public university in Queensland whose Institute for Biomedicine and Glycomics conducted the research.
Molecular Psychiatry
A peer-reviewed scientific journal published by Springer Nature that covers research on the biological basis of psychiatric disorders.
The details
The team removed members of the neurexin gene family to build the models, creating the first complete zebrafish collection lacking this gene family. Behavioural differences appeared only in the juvenile stage, becoming pronounced and persistent, and the study aims to elucidate the biological mechanisms behind these alterations.
Timeline
Early development: zebrafish showed no obvious brain or behaviour changes.
Juvenile stage: behavioural differences emerged and became pronounced.
18 November 2026: results were published in Molecular Psychiatry.
The Big Picture
Zebrafish have become a widely used model in neurodevelopmental genetics because their genes can be altered and their behaviour observed across life stages. This study extends that approach by tracing how neurexin gene loss produces behavioural changes only after early development.
The study is at an early laboratory stage and does not change current treatment options or access. Its value to patients lies in providing a model for identifying future therapies that might prevent or reverse the behavioural changes.
The takeaway
Early laboratory models can reveal when behavioural differences begin, which may help researchers identify points where intervention could be most effective. Readers should treat these findings as foundational research rather than evidence of a new treatment.
Further reading
For more on the research behind these behavioural links, explore our Autism coverage.
Source note: This article includes information reported by PlusNews.






